Catalyst Wire Dossier Catalyst Wire Dossier

GLIADEL

Carmustine · Azurity Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for GLIADEL, covering 2006-12-26 to 2020-03-16. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer [Phase 2]

See pricing